ARROWHEAD PHARMACEUTICALS, INC. short interest in 2024
In 2024, ARROWHEAD PHARMACEUTICALS, INC.'s disclosed short interest ran from 8.27% of shares outstanding on 12 Jan 2024 to 8.05% on 31 Dec 2024, a change of -0.22 percentage points. The year's high was 8.41% on 15 Aug 2024 and its low 6.23% on 31 Jan 2024, averaging 7.48% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.28 days on 31 Jul 2024. Full history: ARROWHEAD PHARMACEUTICALS, INC..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 8.27% (12 Jan 2024)
- End of year
- 8.05% (31 Dec 2024)
- Change
- -0.22 pp
- High
- 8.41% (15 Aug 2024)
- Low
- 6.23% (31 Jan 2024)
- Average
- 7.48%
- Highest days to cover
- 11.28 (31 Jul 2024)
- SEC filings marked
- 8
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 8.27% | 2.86 | |
| 31 Jan 2024 | 6.23% | 7.93 | |
| 15 Feb 2024 | 7.08% | 6.25 | 10-Q filed, results (8-K) |
| 29 Feb 2024 | 7.13% | 4.46 | |
| 15 Mar 2024 | 7.43% | 5.49 | |
| 28 Mar 2024 | 7.16% | 10.92 | |
| 15 Apr 2024 | 7.16% | 10.95 | |
| 30 Apr 2024 | 7.76% | 10.20 | |
| 15 May 2024 | 7.52% | 7.77 | 10-Q filed, results (8-K) |
| 31 May 2024 | 7.26% | 10.91 | |
| 14 Jun 2024 | 7.61% | 8.14 | |
| 28 Jun 2024 | 7.16% | 6.40 | |
| 15 Jul 2024 | 7.28% | 10.86 | |
| 31 Jul 2024 | 8.07% | 11.28 | |
| 15 Aug 2024 | 8.41% | 8.74 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 6.96% | 11.00 | |
| 13 Sep 2024 | 7.28% | 8.54 | |
| 30 Sep 2024 | 7.17% | 7.08 | |
| 15 Oct 2024 | 7.51% | 9.24 | |
| 31 Oct 2024 | 7.55% | 10.47 | |
| 15 Nov 2024 | 7.60% | 7.84 | |
| 29 Nov 2024 | 8.10% | 4.01 | 10-K filed, results (8-K) |
| 13 Dec 2024 | 7.87% | 5.93 | |
| 31 Dec 2024 | 8.05% | 6.99 |
See also: ARROWHEAD PHARMACEUTICALS, INC.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.